Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Philips Respironics

Division of Royal Philips NV
www.respironics.com

Latest From Philips Respironics

ResMed Buys MatrixCare For $750M To Add Skilled-Nursing And Senior-Living Software

ResMed, one of the dominant players in the sleep-disorder market, has signed a definitive deal to buy Minnesota-based MatrixCare to augment its expanding software-as-a-service business with MatrixCare's electronic health record platform for long-term care settings.

Deals M & A

New-Gen Devices Offer Sleep Apnea Patients Alternative CPAP Routes

With half or more of all diagnosed obstructive sleep apnea patients who need continuous positive airway pressure machines unwilling or unable to use these devices, there’s a large unmet need for an alternative treatment. Startups are rising to the challenge with neuromodulation platforms, a mouthguard-like suction device, a nasal device with microblowers, and a vibrating device that nudges patients to turn on their sides.

Respiratory StartUps and SMEs

Medtronic Targets Airway Management, Respiratory Monitoring For Rapid Growth

Medtronic is moving quickly to increase its market share in airway management and respiratory monitoring and is expanding its product portfolio to help hospitals reduce the incidence of respiratory compromise and preventable adverse events. The company recently acquired Aircraft Medical and its video laryngoscopy business, launched its own laryngeal mask product and identified a wide range of potential applications for its fast-growing capnography product line.

Medical Device Innovation

ESC 2015: ‘Shocking’ Outcomes Of Sleep Apnea-Heart Failure Trial Spell Gloom For ResMed

Results from the SERVE-HF trial, presented at the recent European Society of Cardiology meeting and published in the NEJM, showed systolic heart failure patients with central sleep apnea treated with adaptive servo-ventilation actually had worse mortality outcomes than the control group. These results "shocked " both the respiratory and cardiology community and spell gloom for ResMed's sleep apnea therapy.

Medical Device Clinical Trials
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register